Assignee
PORTOLA PHARM INC
US·49 granted patents·43 pending applications·363 citations·filing 1999–2020
Top patents by PatentIndex Score
92 records- 0195US9388401B2Antidotes for factor Xa inhibitors and methods of using the samePORTOLA PHARM INC·Filed 2014·Granted Jul 12, 2016·18 cites·19 claims
- 0295US9062298B2Antidotes for factor XA inhibitors and methods of using the samePORTOLA PHARM INC·Filed 2013·Granted Jun 23, 2015·21 cites·18 claims
- 0395US8889129B2Antidotes for factor Xa inhibitors and methods of using the samePORTOLA PHARM INC·Filed 2013·Granted Nov 18, 2014·18 cites·22 claims
- 0494US8937070B2Inhibitors of protein kinasesPORTOLA PHARM INC·Filed 2013·Granted Jan 20, 2015·16 cites·7 claims
- 0594US8349860B2Inhibitors of syk and JAK protein kinasesPORTOLA PHARM INC·Filed 2011·Granted Jan 8, 2013·9 cites·2 claims
- 0693US11028382B2Lyophilized formulations for factor Xa antidotePORTOLA PHARM INC·Filed 2020·Granted Jun 8, 2021·3 cites·9 claims
- 0793US9587233B2Antidotes for factor XA inhibitors and methods of using the samePORTOLA PHARM INC·Filed 2015·Granted Mar 7, 2017·10 cites·7 claims
- 0892US9868729B2Inhibitors of protein kinasesPORTOLA PHARM INC·Filed 2014·Granted Jan 16, 2018·12 cites·12 claims
- 0992US8952027B2Inhibitors of syk and JAK protein kinasesPORTOLA PHARM INC·Filed 2012·Granted Feb 10, 2015·6 cites·21 claims
- 1092US8853230B2Inhibitors of JAKPORTOLA PHARM INC·Filed 2012·Granted Oct 7, 2014·19 cites·14 claims
- 1192US7705004B2Protein kinase inhibitorsPORTOLA PHARM INC·Filed 2008·Granted Apr 27, 2010·22 cites·17 claims
- 1292US6906063B2Platelet ADP receptor inhibitorsPORTOLA PHARM INC·Filed 2001·Granted Jun 14, 2005·34 cites·8 claims
- 1391US10675335B2Antidotes for factor Xa inhibitors and methods of using the samePORTOLA PHARM INC·Filed 2016·Granted Jun 9, 2020·3 cites·3 claims
- 1491US7022731B2Platelet ADP receptor inhibitorsPORTOLA PHARM INC·Filed 2004·Granted Apr 4, 2006·22 cites·12 claims
- 1590US10765726B2Unit dose formulation of antidotes for factor Xa inhibitors and methods of using the samePORTOLA PHARM INC·Filed 2017·Granted Sep 8, 2020·3 cites·20 claims
- 1690US7358091B2Device and methods for identifying and treating aspirin non-responsive patientsPORTOLA PHARM INC·Filed 2005·Granted Apr 15, 2008·23 cites·14 claims
- 1789US6689786B2Platelet ADP receptor inhibitorsPORTOLA PHARM INC·Filed 2003·Granted Feb 10, 2004·24 cites·13 claims
- 1888US10533001B2Inhibitors of protein kinasesPORTOLA PHARM INC·Filed 2017·Granted Jan 14, 2020·4 cites·13 claims
- 1988US8367689B2Inhibitors of JAKPORTOLA PHARM INC·Filed 2010·Granted Feb 5, 2013·11 cites·27 claims
- 2087US8877760B2Substituted pyrazine-2-carboxamide kinase inhibitorsPORTOLA PHARM INC·Filed 2012·Granted Nov 4, 2014·8 cites·5 claims
- 2187US7678913B2Ureas as factor Xa inhibitorsPORTOLA PHARM INC·Filed 2005·Granted Mar 16, 2010·9 cites·34 claims
- 2286US10190111B2Antidotes for factor Xa inhibitors and methods of using the samePORTOLA PHARM INC·Filed 2017·Granted Jan 29, 2019·3 cites·10 claims
- 2386US7358257B2Platelet ADP receptor inhibitorsPORTOLA PHARM INC·Filed 2005·Granted Apr 15, 2008·7 cites·10 claims
- 2485US10736895B2Cerdulatinib for treating hematological cancersPORTOLA PHARM INC·Filed 2016·Granted Aug 11, 2020·3 cites·24 claims
- 2585US7834023B2Substituted dihydroquinazolines as platelet ADP receptor inhibitorsPORTOLA PHARM INC·Filed 2007·Granted Nov 16, 2010·4 cites·26 claims
- 2684US7785891B2Device and methods for identifying and treating aspirin non-responsive patientsPORTOLA PHARM INC·Filed 2008·Granted Aug 31, 2010·10 cites·11 claims
- 2783US9676756B2Substituted pyrimidinyl kinase inhibitorsPORTOLA PHARM INC·Filed 2013·Granted Jun 13, 2017·6 cites·23 claims
- 2883US9359375B2Benzamides and nicotinamides as Syk modulatorsPORTOLA PHARM INC·Filed 2014·Granted Jun 7, 2016·5 cites·15 claims
- 2982US10865198B2Solid forms of cerdulatinibPORTOLA PHARM INC·Filed 2019·Granted Dec 15, 2020·3 cites·40 claims
- 3082US10604748B2Preparation of factor Xa derivativesPORTOLA PHARM INC·Filed 2017·Granted Mar 31, 2020·3 cites·27 claims
- 3176US10851087B2Synthesis of cerdulatinibPORTOLA PHARM INC·Filed 2019·Granted Dec 1, 2020·1 cites·41 claims
- 3276US9533986B2Bicyclic dihydropyridone kinase inhibitorsPORTOLA PHARM INC·Filed 2013·Granted Jan 3, 2017·3 cites·18 claims
- 3376US9469654B2Bicyclic oxa-lactam kinase inhibitorsPORTOLA PHARM INC·Filed 2013·Granted Oct 18, 2016·3 cites·20 claims
- 3475US7205296B2Substituted 2H-1,3-benzoxazin-4(3H)-onesPORTOLA PHARM INC·Filed 2005·Granted Apr 17, 2007·2 cites·27 claims
- 3574US7056926B2Platelet ADP receptor inhibitorsPORTOLA PHARM INC·Filed 2004·Granted Jun 6, 2006·4 cites·20 claims
- 3671US2019127720A1Process for making recombinant antidote to factor xa inhibitorPORTOLA PHARM INC·Filed 2018·Application pending·0 cites
- 3771US2021085762A1Unit dose formulation of antidotes for factor xa inhibitors and methods of using the samePORTOLA PHARM INC·Filed 2020·Application pending·0 cites
- 3870US9579320B2Inhibitors of syk and JAK protein kinasesPORTOLA PHARM INC·Filed 2014·Granted Feb 28, 2017·0 cites·3 claims
- 3969US7294635B2Substituted isoquinolinonesPORTOLA PHARM INC·Filed 2004·Granted Nov 13, 2007·4 cites·30 claims
- 4068US2011212983A1Platelet adp receptor inhibitorsPORTOLA PHARM INC·Filed 2009·Application pending·0 cites
- 4167US2018320160A1Lyophilized formulations for factor xa antidotePORTOLA PHARM INC·Filed 2017·Application pending·0 cites
- 4266US2017240879A1Process for making recombinant antidote to factor xa inhibitorPORTOLA PHARM INC·Filed 2016·Application pending·0 cites
- 4366US2020129597A1MODULATION OF FACTOR Xa INHIBITOR-MEDIATED BLOOD LOSS BY PARTIAL AND TRANSIENT ADMINISTRATION OF ANTIDOTEPORTOLA PHARM INC·Filed 2019·Application pending·0 cites
- 4465US2013230901A1Process for making recombinant antidote to factor xa inhibitorPORTOLA PHARM INC·Filed 2013·Application pending·0 cites
- 4565US2017014492A1Unit dose formulation of antidotes for factor xa inhibitors and methods of using the samePORTOLA PHARM INC·Filed 2016·Application pending·0 cites
- 4663US7622474B2Platelet ADP receptor inhibitorsPORTOLA PHARM INC·Filed 2007·Granted Nov 24, 2009·0 cites·8 claims
- 4763US2015352194A1Inhibition of tissue factor pathway inhibitor with factor xa derivativesPORTOLA PHARM INC·Filed 2013·Application pending·0 cites
- 4863US2015376592A1Process for making recombinant antidote to factor xa inhibitorPORTOLA PHARM INC·Filed 2015·Application pending·0 cites
- 4963US2015025011A1Unit dose formulation of antidotes for factor xa inhibitors and methods of using the samePORTOLA PHARM INC·Filed 2014·Application pending·0 cites
- 5063US2018333469A1Inhibition of tissue factor pathway inhibitor with factor xa derivativesPORTOLA PHARM INC·Filed 2018·Application pending·0 cites
Showing the top 50 of 92 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →